Study identifies novel inhibitors against SARS-CoV-2 main protease

AI background business technology, digital transformation

In a recent study posted to the bioRxiv* server, researchers at the University of Arizona screened ~11 million severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (MPro)-inhibiting small compounds in the ZINC15 database using a structure-based in-silico screening method.

Cell competition could be responsible for cancer relapses, study shows

Previous article

Research estimates the changing burden of COVID-19 in Austin, Texas

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News